Jianjun Zhang1, Zhenfeng Shi1, Yukui Nan1, Ming Li2. 1. Department of Urology Surgery Center, The People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, 830002, Xinjiang, People's Republic of China. 2. Department of Urology Surgery Center, The People's Hospital of Xinjiang Uyghur Autonomous Region, Urumqi, 830002, Xinjiang, People's Republic of China. mingli23455@sina.com.
Abstract
BACKGROUND AND OBJECTIVES: Long noncoding RNAs (lncRNAs) play key roles in process of cancer cell growth and apoptosis and have received increasing attention. SChLAP1 is a novel lncRNA that is required for development and progression of prostate cancer. We hypothesized that SChLAP1 also has important biological functions in human bladder cancer which is another type of urological cancer. METHODS: The expression of SChLAP1 in bladder cancer was determined using real-time qPCR. Bladder cancer T24 and 5637 cells were transfected with SChLAP1 siRNA or negative control siRNA. Cell proliferation, apoptosis and migration were determined using CCK-8 assay, flow cytometry analysis and wound healing assay, respectively. RESULTS: SChLAP1 was overexpressed in bladder cancer tissues compared to paired normal bladder tissues. Cell growth arrest, apoptosis induction and migration inhibition were also observed in bladder cancer T24 and 5637 cells after transfection with SChLAP1 siRNA. CONCLUSIONS: Our data suggest that SChLAP1 plays oncogenic roles and can be used as a therapeutic target for treating human bladder cancer.
BACKGROUND AND OBJECTIVES: Long noncoding RNAs (lncRNAs) play key roles in process of cancer cell growth and apoptosis and have received increasing attention. SChLAP1 is a novel lncRNA that is required for development and progression of prostate cancer. We hypothesized that SChLAP1 also has important biological functions in humanbladder cancer which is another type of urological cancer. METHODS: The expression of SChLAP1 in bladder cancer was determined using real-time qPCR. Bladder cancer T24 and 5637 cells were transfected with SChLAP1 siRNA or negative control siRNA. Cell proliferation, apoptosis and migration were determined using CCK-8 assay, flow cytometry analysis and wound healing assay, respectively. RESULTS:SChLAP1 was overexpressed in bladder cancer tissues compared to paired normal bladder tissues. Cell growth arrest, apoptosis induction and migration inhibition were also observed in bladder cancer T24 and 5637 cells after transfection with SChLAP1 siRNA. CONCLUSIONS: Our data suggest that SChLAP1 plays oncogenic roles and can be used as a therapeutic target for treating humanbladder cancer.
Authors: Rohit Mehra; Aaron M Udager; Thomas U Ahearn; Xuhong Cao; Felix Y Feng; Massimo Loda; Joshua S Petimar; Philip Kantoff; Lorelei A Mucci; Arul M Chinnaiyan Journal: Eur Urol Date: 2015-12-24 Impact factor: 20.096
Authors: John R Prensner; Matthew K Iyer; Anirban Sahu; Irfan A Asangani; Qi Cao; Lalit Patel; Ismael A Vergara; Elai Davicioni; Nicholas Erho; Mercedeh Ghadessi; Robert B Jenkins; Timothy J Triche; Rohit Malik; Rachel Bedenis; Natalie McGregor; Teng Ma; Wei Chen; Sumin Han; Xiaojun Jing; Xuhong Cao; Xiaoju Wang; Benjamin Chandler; Wei Yan; Javed Siddiqui; Lakshmi P Kunju; Saravana M Dhanasekaran; Kenneth J Pienta; Felix Y Feng; Arul M Chinnaiyan Journal: Nat Genet Date: 2013-09-29 Impact factor: 38.330
Authors: Frederikke Lihme Egerod; Annette Bartels; Niels Fristrup; Michael Borre; Torben F Ørntoft; Martin B Oleksiewicz; Nils Brünner; Lars Dyrskjøt Journal: BMC Cancer Date: 2009-10-30 Impact factor: 4.430
Authors: Rohit Mehra; Yang Shi; Aaron M Udager; John R Prensner; Anirban Sahu; Matthew K Iyer; Javed Siddiqui; Xuhong Cao; John Wei; Hui Jiang; Felix Y Feng; Arul M Chinnaiyan Journal: Neoplasia Date: 2014-12 Impact factor: 5.715
Authors: Aleksandra M Dudek; Sabrina J Boer; Nanda Boon; J Alfred Witjes; Lambertus A L M Kiemeney; Gerald W Verhaegh Journal: Oncotarget Date: 2017-05-23